TY - JOUR

T1 - Latest advances in aging research and drug discovery

AU - Bakula, Daniela

AU - Ablasser, Andrea

AU - Aguzzi, Adriano

AU - Antebi, Adam

AU - Barzilai, Nir

AU - Bittner, Martin Immanuel

AU - Jensen, Martin Borch

AU - Calkhoven, Cornelis F.

AU - Chen, Danica

AU - de Grey, Aubrey D.N.J.

AU - Feige, Jerome N.

AU - Georgievskaya, Anastasia

AU - Gladyshev, Vadim N.

AU - Golato, Tyler

AU - Gudkov, Andrei V.

AU - Hoppe, Thorsten

AU - Kaeberlein, Matt

AU - Katajisto, Pekka

AU - Kennedy, Brian K.

AU - Lal, Unmesh

AU - Martin-Villalba, Ana

AU - Moskalev, Alexey A.

AU - Ozerov, Ivan

AU - Petr, Michael A.

AU - Reason, null

AU - Rubinsztein, David C.

AU - Tyshkovskiy, Alexander

AU - Vanhaelen, Quentin

AU - Zhavoronkov, Alex

AU - Scheibye-Knudsen, Morten

PY - 2019

Y1 - 2019

N2 - An increasing aging population poses a significant challenge to societies worldwide. A better understanding of the molecular, cellular, organ, tissue, physiological, psychological, and even sociological changes that occur with aging is needed in order to treat age-associated diseases. The field of aging research is rapidly expanding with multiple advances transpiring in many previously disconnected areas. Several major pharmaceutical, biotechnology, and consumer companies made aging research a priority and are building internal expertise, integrating aging research into traditional business models and exploring new go-to-market strategies. Many of these efforts are spearheaded by the latest advances in artificial intelligence, namely deep learning, including generative and reinforcement learning. To facilitate these trends, the Center for Healthy Aging at the University of Copenhagen and Insilico Medicine are building a community of Key Opinion Leaders (KOLs) in these areas and launched the annual conference series titled "Aging Research and Drug Discovery (ARDD)" held in the capital of the pharmaceutical industry, Basel, Switzerland (www.agingpharma.org). This ARDD collection contains summaries from the 6th annual meeting that explored aging mechanisms and new interventions in age-associated diseases. The 7th annual ARDD exhibition will transpire 2nd-4th of September, 2020, in Basel.

AB - An increasing aging population poses a significant challenge to societies worldwide. A better understanding of the molecular, cellular, organ, tissue, physiological, psychological, and even sociological changes that occur with aging is needed in order to treat age-associated diseases. The field of aging research is rapidly expanding with multiple advances transpiring in many previously disconnected areas. Several major pharmaceutical, biotechnology, and consumer companies made aging research a priority and are building internal expertise, integrating aging research into traditional business models and exploring new go-to-market strategies. Many of these efforts are spearheaded by the latest advances in artificial intelligence, namely deep learning, including generative and reinforcement learning. To facilitate these trends, the Center for Healthy Aging at the University of Copenhagen and Insilico Medicine are building a community of Key Opinion Leaders (KOLs) in these areas and launched the annual conference series titled "Aging Research and Drug Discovery (ARDD)" held in the capital of the pharmaceutical industry, Basel, Switzerland (www.agingpharma.org). This ARDD collection contains summaries from the 6th annual meeting that explored aging mechanisms and new interventions in age-associated diseases. The 7th annual ARDD exhibition will transpire 2nd-4th of September, 2020, in Basel.

KW - Aging

KW - Artificial intelligence

KW - Drug discovery

U2 - 10.18632/aging.102487

DO - 10.18632/aging.102487

M3 - Journal article

C2 - 31770722

AN - SCOPUS:85076017831

VL - 11

SP - 9971

EP - 9981

JO - Aging

JF - Aging

SN - 1945-4589

IS - 22

ER -